Pikumil Pikumil
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Reels
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Forums
  • Movies
  • Oyunlar
  • Yazı
  • Blogs
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • Akshay Gorde bir ses eklendi Health
    2026-09-21 17:21:19 -
    Erythropoietin (EPO) Drugs Market Growth, Overview and Forecast Analysis By Fact.MR
    ROCKVILLE, MARYLAND , Sept 21, 2026 — The global erythropoietin (EPO) drugs market is projected to grow from USD 13.8 billion in 2026 to USD 22.7 billion by 2036, registering a compound annual growth rate (CAGR) of 5.1% during the forecast period. The market was valued at USD 13.1 billion in 2025, driven by recurring renal-anemia treatment demand. Absolute opportunity is...
    0 Yorumlar 0 hisse senetleri 50 Views 0 önizleme
    Please log in to like, share and comment!
  • Matt Watson bir ses eklendi Health
    2026-09-18 12:23:03 -
    Erythropoietin Drugs Market 2026: Size, Share, Industry Trends, Growth and Forecast to 2034
    According to IMARC Group, the global erythropoietin drugs market size reached USD 12,097.4 Million in 2025 and is projected to reach USD 18,184.2 Million by 2034, expanding at a CAGR of 4.49% during 2026-2034. This steady growth trajectory reflects the rising global burden of chronic kidney disease and cancer, continuous innovation in biopharmaceutical research, and the accelerating shift...
    0 Yorumlar 0 hisse senetleri 57 Views 0 önizleme
    Please log in to like, share and comment!
  • Matt Watson bir ses eklendi Health
    2026-09-22 12:39:33 -
    Erythropoietin Drugs Market Size, Share, Latest Insights and Forecast 2026-2034
    According to IMARC Group, the global erythropoietin drugs market size reached USD 12,097.4 Million in 2025 and is projected to reach USD 18,184.2 Million by 2034, expanding at a CAGR of 4.49% during 2026-2034. This steady growth trajectory reflects the rising global burden of chronic kidney disease and cancer, continuous innovation in biopharmaceutical research, and the accelerating shift...
    0 Yorumlar 0 hisse senetleri 64 Views 0 önizleme
    Please log in to like, share and comment!
© 2026 Pikumil Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Bengali
About Koşullar Gizlilik Contact Us Rehber